Melanoma in Organ Transplant Recipients: Clinicopathological Features and Outcome in 100 Cases

Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald et al. · Journal of Clinical Oncology · 2001 · 2.4K citations

Medicine, Dermatology, Oncology +17

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

Markus Guba, Philipp von Breitenbuch, Markus Steinbauer et al. · Nature Medicine · 2002 · 1.7K citations

Medicine, Oncology, Pharmacology +16

Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma Patients

Jeffrey E. Gershenwald, William Thompson, Jeffrey E. Lee et al. · Journal of Clinical Oncology · 1999 · 1.1K citations

Medicine, Oncology, Surgery +17

Cancer after Kidney Transplantation in the United States

Bertram L. Kasiske, Jon J. Snyder, David T. Gilbertson et al. · American Journal of Transplantation · 2004 · 1.1K citations

Medicine, Oncology, Surgery +14

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

Petter Jensen, Svein Hansen, Bjørn Møller et al. · Journal of the American Academy of Dermatology · 1999 · 876 citations

Medicine, Dermatology, Oncology +16